Related references
Note: Only part of the references are listed.Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models
N-H Kang et al.
CANCER GENE THERAPY (2012)
Stem cells with fused gene expression of cytosine deaminase and interferon-β migrate to human gastric cancer cells and result in synergistic growth inhibition for potential therapeutic use
Kyoung-Yoon Kim et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Influence of the prodrugs 5-fluorocytosine and CPT-11 on ovarian cancer cells using genetically engineered stem cells: tumor-tropic potential and inhibition of ovarian cancer cell growth
Ki-Yon Kim et al.
CANCER SCIENCE (2010)
Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model
Mi-Hyeon You et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
An improved human carboxylesterase for enzyme/prodrug therapy with CPT-11
M. Wierdl et al.
CANCER GENE THERAPY (2008)
Stem and progenitor cell-mediated tumor selective gene therapy
K. S. Aboody et al.
GENE THERAPY (2008)
Endogenous Matrix Metalloproteinase (MMP)-3 and MMP-9 Promote the Differentiation and Migration of Adult Neural Progenitor Cells in Response to Chemokines
Basam Z. Barkho et al.
STEM CELLS (2008)
Patients with a family history of cancer: Identification and management
MM Eberl et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY PRACTICE (2005)
Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects
DP Dearnaley et al.
BRITISH JOURNAL OF CANCER (2005)
Combined 5-fluorouracil/systemic interferon-β gene therapy results in long-term survival in mice with established colorectal liver metastases
EA Choi et al.
CLINICAL CANCER RESEARCH (2004)
Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1α/CXC chemokine receptor 4 pathway
J Imitola et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease
R Martiniello-Wilks et al.
JOURNAL OF GENE MEDICINE (2004)
Mesenchymal stem cells: Potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents
M Studeny et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
DP Petrylak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: Efficacy of flt3 ligand immunotherapy
KD Somers et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Signal pathway profiling of prostate cancer using reverse phase protein arrays
RL Grubb et al.
PROTEOMICS (2003)
Secreted and tumour targeted human carboxylesterase for activation of irinotecan
D Oosterhoff et al.
BRITISH JOURNAL OF CANCER (2002)
Delineation of prognostic biomarkers in prostate cancer
SM Dhanasekaran et al.
NATURE (2001)
Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages
Y Zhang et al.
MOLECULAR THERAPY (2001)
Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup
P Iversen et al.
JOURNAL OF UROLOGY (2000)
Isolation and characterization of a cDNA encoding a horse liver butyrylcholinesterase - Evidence for CPT-11 drug activation
M Wierdl et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Share Paper
